DL‐PDT for AK: multicentre trial comparing BF‐200 ALA with MAL
Janne Räsänen(Tampere University Hospital), M Grönroos(Päijät-Hämeen Keskussairaala), Pekka Rissanen(Tampere University), Noora Neittaanmäki(University of Helsinki), Leea Ylitalo(Tampere University Hospital), Lasse Ylianttila(Radiation and Nuclear Safety Authority), Mari Salmivuori(Tampere University Hospital), Erna Snellman(Tampere University Hospital), J. Hagman(University of Turku)
Cited by 1
Related Papers
A clinical benchmark of public self-supervised pathology foundation models
|Nature Communications|2025|93
Daylight photodynamic therapy for actinic keratoses: a randomized double‐blinded nonsponsored prospective study comparing 5‐aminolaevulinic acid nanoemulsion ( <scp>BF</scp> ‐200) with methyl‐5‐aminolaevulinate
|British Journal of Dermatology|2014|76
Attitudes Toward Artificial Intelligence Within Dermatopathology: An International Online Survey
|Frontiers in Medicine|2020|51
Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection
|Nature Medicine|2025|50
Detecting field cancerization using a hyperspectral imaging system
|Lasers in Surgery and Medicine|2013|43